Healthcare Sector

Members of Parliament invested in the Healthcare Sector

157 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£128.12	196.30%	£207,409.79
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£128.12	177.74%	£194,415.77
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,900.00	15.60%	£80,921.49
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,900.00	237.71%	£236,394.56
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,900.00	87.28%	£131,096.74
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,900.00	18.06%	£82,639.71
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,900.00	421.28%	£364,897.81
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,900.00	14.35%	£80,042.78
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,900.00	156.60%	£179,619.72
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,900.00	16.57%	£81,600.13
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,900.00	35.87%	£95,112.41
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,900.00	73.64%	£121,549.03
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,900.00	373.11%	£331,177.67
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.74	-77.64%	£15,649.55
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£54.47	45.68%	£101,976.47
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£54.47	27.33%	£89,128.10
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£54.47	38.32%	£96,823.26
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£54.47	28.74%	£90,118.18
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£54.47	37.93%	£96,553.56
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£54.47	21.72%	£85,204.47
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£54.47	23.74%	£86,617.45
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£54.47	45.76%	£102,031.05
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£227.79	38.03%	£96,620.61
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£227.79	85.74%	£130,017.12
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£227.79	213.37%	£219,360.28
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£225.34	269.83%	£258,883.96
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£227.79	40.85%	£98,598.19
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£178.98	148.05%	£173,636.32
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£198.61	-20.20%	£55,860.39**
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£366.77	44.84%	£101,389.70
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£366.77	-25.16%	£52,389.30
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£366.77	-31.81%	£47,736.08
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£366.77	-29.22%	£49,544.38
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£366.77	-38.30%	£43,192.96
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,262.48	87.73%	£131,412.51
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£470.22	12.46%	£78,718.61
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£470.22	2.39%	£71,673.64
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£470.22	-19.43%	£56,396.75
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£470.22	1.55%	£71,085.43
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£468.04	-1.96%	£68,626.13
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£112.60	-81.62%	£12,866.47
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£112.60	-64.81%	£24,631.25
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£41.17	13.26%	£79,281.98
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£41.17	-59.51%	£28,340.05
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£41.20	-66.44%	£23,494.91
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£41.17	-69.43%	£21,401.31
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£116.65	-30.61%	£48,575.25
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£116.65	-28.36%	£50,150.47
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£145.50	64.63%	£115,241.01
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£145.50	120.29%	£154,205.13
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£145.50	169.24%	£188,467.25
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£160.60	-29.41%	£49,415.39
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£321.10	27.50%	£89,247.57
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£321.10	3.70%	£72,588.41
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£321.10	25.53%	£87,869.43
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£321.10	5.97%	£74,181.52
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£321.10	3.92%	£72,741.10
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£93.86	271.48%	£260,038.41
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£93.86	-13.75%	£60,376.77
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£93.86	185.29%	£199,702.12
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.22	-84.96%	£10,527.67
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.48	35.49%	£94,839.53
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.48	-8.76%	£63,867.09
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£31.08	37.49%	£96,244.01
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£31.08	48.14%	£103,696.82
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£300.73	245.31%	£241,716.63
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£321.43	363.02%	£324,115.53
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£321.43	16.88%	£81,818.54
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£45.75	-4.29%	£66,997.91
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£45.75	-16.74%	£58,280.25
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£9.95	-22.33%	£54,371.58
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£81.90	-18.73%	£56,891.94
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£80.98	1.94%	£71,357.00
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£36.62	-61.56%	£26,909.51
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£177.28	-35.24%	£45,331.87
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£197.69	22.93%	£86,053.73
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£466.64	67.95%	£117,562.71
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£466.64	33.03%	£93,117.82
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£466.64	-15.36%	£59,250.50
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£431.92	1,292.39%	£974,674.43
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£25.00	-0.04%	£69,971.45
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,304.00	-13.97%	£60,224.05
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£568.30	1,796.86%	£1,327,803.75
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£874.00	19.51%	£83,655.80
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£874.00	-8.50%	£64,050.08
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,397.00	-31.05%	£48,267.52
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£1.01	-97.67%	£1,633.17
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£744.30	33.63%	£93,538.60
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£6.20	342.86%	£309,999.99
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.24	16.67%	£81,666.67
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.75	-27.50%	£50,750.00
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£34.58	129.77%	£160,837.22
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.55	-95.42%	£3,208.33
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£13.03	22.69%	£85,885.12
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£9.50	-15.56%	£59,111.11
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£49.54	64.69%	£115,285.91
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£47.14	-57.90%	£29,467.76
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£350.80	4.37%	£73,061.58
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£4.20	-66.80%	£23,241.11
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£186.45	-10.14%	£62,898.79
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£182.70	-33.13%	£46,811.86
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.52	-97.98%	£1,413.46
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£75.50	-32.59%	£47,187.50
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£73.60	42.91%	£100,038.83
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.07	558.67%	£461,070.43
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.76	-87.47%	£8,773.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.53	-10.63%	£62,556.96

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.